Restoration of endothelial function via enhanced nitric oxide synthesis after long-term treatment of raloxifene in adult hypertensive rats

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 2, 2005, Pages 86-92

  Leitzbach, Daniela ^a   Weckler, Nadine ^a   Madajka, Maria ^b   Malinski, Tadeusz ^b   Wiemer, Gabriele ^a   Linz, Wolfgang ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b OHIO UNIVERSITY   (United States)

Author keywords

Cas 84449 90 1; Endothelial dysfunction; Estrogen receptor modulators, selective; Nitric oxide; Raloxifene, effect on endothelial dysfunction, long term treatment, spontaneously hypertensive rats

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CALCIUM IONOPHORE; NITRIC OXIDE; PHENYLEPHRINE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG MECHANISM; ELECTROCHEMICAL ANALYSIS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GENE AMPLIFICATION; HYPERTENSION; LONG TERM EXPOSURE; MALE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; POSTMENOPAUSE OSTEOPOROSIS; RAT; STATISTICAL SIGNIFICANCE;

EID: 14744276790     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296828     Document Type: Article

References (32)

1. Jousilahti, P., Vartiainen, E., Tuomilehto, J. et al., Sex, age, cardiovascular risk factors and coronary heart disease. Circulation 99, 1165 (1999)
2. Castelli, W. P., Epidemiology of coronary heart disease: the Framingham Study. Am. J. Med. 76, 4 (1984)
3. Kuhn, F. E., Rackley, C. E., Coronary artery disease in women: risk factors, evaluation, treatment, and prevention. Arch. Intern. Med. 153, 2626 (1993)
4. Grodstein, F., Stampfer, M. J., Colditz, G. A. et al., Post-menopausal hormone therapy and mortality. N. Engl. J. Med. 336, 1769 (1997)
5. Mendelsohn, M. E., Karas, R. H., The protective effects of estrogen on the cardiovascular system. Mass. Med. Soc. 340, 1801 (1999)
6. Al-Azzawi, F., Hart, D. M., Lindsay, R., Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry. Br. Med. J. 294, 1261 (1987)
7. Colditz, G. A., Hankinson, S. E., Hunter, D. J. et al., The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332, 1589 (1995)
8. Daly E., Vessey, M. P., Hawkins, M. M. et al., Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348, 977 (1996)
9. Mitlak, B. H., Cohen, F. J., Selective estrogen receptor modulators. A look ahead. Drugs 57, 653 (1999)
10. Goldfrank, D., Haytoglu, T., Frishman, W. H. et al., Raloxifene, a new selective estrogen receptor modulator. J. Clin. Pharmacol. 39, 767 (1999)
11. Figtree, G. A., Lu, Y.-Q., Webb, C.M. et al., Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation 100, 1095 (1999)
12. Laufs, U., Fata, V. L., Plutzky, J. et al., Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129 (1998)
13. Malinski, T., Taha, Z., Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358, 676 (1992)
14. Malinski, T., Czuchajowski, L. Nitric oxide measurements by electrochemical methods. In: M. Feelish, J. S. Stamler (eds.), Methods of Nitric Oxide Research, p. 319. John Wiley & Sons, New York (1996)
15. Lvovich, V., Scheeline, A., Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection. Anal. Chem. 69, 454 (1997)
16. Mesaros, S., Vankova, Z., Grunfeld, S. et al., Preparation and optimization of superoxide microsensor. Anal. Chim. Acta 358, 27 (1998)
17. Malinski, T., Kubaszewski, E., Kiechle, F., Electrochemical and spectroscopic methods of nitric oxide detection. Methods Neurosci. 31, 14 (1996)
18. Wang, P., Zweierm, J. L., Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. J. Biol. Chem. 271, 29223 (1996)
19. Voegel, R. A., Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin. Cardiol. 20, 426 (1997)
20. Rossouw, J. E., Hormone replacement therapy and cardiovascular disease. Curr. Opin. Lipidol. 10, 429 (1999)
21. Schächinger, V., Britten, M. B., Zeiher, A. M., Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899 (2000)
22. Harrison, D. G., Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Clin. Cardiol. 20, II11 (1997)
23. Schwartz, J., Freeman, R., Frishman, W. H., Clinical pharmacology of estrogens: focus on their cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J. Clin. Pharmacol. 35, 314 (1995)
24. Bjarnason, N. H., Haarbo, J., Byrjalsen, I. et al., Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation. 96, 1964 (1997)
25. Wassmann, S., Laufs, U., Stamenkovic, D. et al., Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105, 2083 (2002)
26. Wirth, K. J., Linz, W., Wiemer, G. et al., Differences in acetylcholine- and bradykinin-induced vasorelaxation of the mesenteric vascular bed in spontaneously hypertensive rats of different ages. Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 38 (1996)
27. Vaziri, N. D., Ni, Z., Oveisi, F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31, 1248 (1998)
28. Huk, I., Nanobashvili, J., Neumayer, C. et al., L-Arginine Treatment Alters the Kinetics of Nitric Oxide and Superoxide Release and Reduces Ischemia/Reperfusion Injury in Skeletal Muscle. Circulation 96, 667 (1997)
29. Zoma, W. D., Baker, R., Clark, K. E., Coronary and uterine vascular responses to raloxifene in the sheep. Am. J. Obstet. Gynecol. 182, 521 (2000)
30. Rahimian, R., Dube, G. P., Toma, W. et al., Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur. J. Pharmacol. 434, 141 (2002)
31. Simoncini, T., Genazzana, A. R., Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J. Clin. Endocrinol. Metab. 85, 2966 (2000)
32. Kalinowski, L., Dobrucki, L., Brovkovych, V. et al., Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation. 105, 933 (2002)